HanAll Biopharma Announces First Quarter 2021 Results
HanAll Biopharma Announces First Quarter 2021 Results Q1'21 operating profit of KRW 5.4 billion increased 80% compared to Q1'20 Q1'21 operating margin of 19%, up from 14% in Q1'20 Better-than-expected sales and operating profit are largely due to an increase of R&D revenue including milestone payment SEOUL, South Korea, May 6, 2021 /PRNewswire/ -- HanAll Biopharma (KRX: 009420) (HanAll) announced on the 29th, Apr. that it achieved 27.8 billion won in sales, 5.4 billion won in operating profit and 4.5 billion won in net profit in the first quarter of this year. Sales and operating profit ro...
Source: finanznachrichten.de